Logo

Sanofi Collaborates with Translate Bio to Develop Novel mRNA Vaccine Against COVID-19

Share this

Sanofi Collaborates with Translate Bio to Develop Novel mRNA Vaccine Against COVID-19

Shots:

  • Translate Bio will utilize its mRNA platform to discover- design- and manufacture SARS-CoV-2 vaccine candidates while Sanofi will provide its vaccine expertise in advancing the vaccine candidates for further development
  • The collaboration leverages the existing 2018 agreement signed b/w the companies for developing mRNA vaccines for infectious diseases
  • The collaboration marks the Sanofi’s second collaboration for developing vaccine candidates against COVID-19. Initially- the company has collaborated with BARDA to advance vaccine candidates in Feb’2020

Click here ­to­ read full press release/ article | Ref: Sanofi | Image: WFMZ


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions